Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Societal CDMO, Inc.

Societal CDMO, Inc. (SCTL) Stock Overview

Explore Societal CDMO, Inc.’s financial performance, market position, analyst ratings, and future outlook.

SCTL●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$1.10
$0.01(0.92%)
U.S. Market is Open · 13:56

Societal CDMO, Inc. (SCTL)

Meyka AI Score

Z

Key Financials

Market Cap116.1M
P/E Ratio-7.86
EPS (TTM)$-0.14
ROE-0.22%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

SCTL Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Societal CDMO, Inc. (NASDAQ: SCTL) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Societal CDMO, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of SCTL on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Societal CDMO, Inc.'s NASDAQ-traded stock include a P/E ratio of -7.86 and a market capitalization of 116.1M. Combined with our AI analysis, these give both institutional and retail investors a clear view of SCTL on the NASDAQ.

Price Performance (NASDAQ: SCTL)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
144.39%
6-Month Change
205.47%
Year-to-Date (YTD) Change
168.10%
1-Year Change
57.14%
3-Year Change
-56.18%
5-Year Change
-86.47%
All-Time (Max) Change
-85.22%

Contact Information

https://www.bendbioscience.com
770 534 8239
1 E. Uwchlan Ave, Exton, PA, 19341

Company Facts

2,580 Employees
IPO DateMar 7, 2014
CountryUS

Frequently Asked Questions